Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Medical Oncology (Northwood, London, England)
|
July 13, 2016
Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial
Fabien Calcagno, Guillaume Mouillet, Olivier Adotevi, et al.
Frontiers in Oncology
|
March 28, 2022
Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients
Emeline Orillard, Julie Henriques, Dewi Vernerey, et al.
Journal of Adolescent and Young Adult Oncology
|
February 27, 2026
Impact of Social Media on Adolescents and Young Adults with Solid Tumors or Hematological Malignancies: A Multicenter Study
Sophie Martin, Justine Gantzer, Natacha Entz-Werle, et al.
Bulletin Du Cancer
|
July 5, 2020
[Systemic treatment of locally advanced or metastatic penile cancer]
Noémie Gassian, Alexandre Frontczak, Antoine El Kaddissi, et al.
Trials
|
April 14, 2018
Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial
Guillaume Mouillet, Marie-Justine Paillard, Tristan Maurina, et al.
Stem Cells (Dayton, Ohio)
|
May 10, 2008
Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney
Céline Mias, Elodie Trouche, Marie-Hélène Seguelas, et al.
Bulletin Du Cancer
|
October 1, 2021
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network]
Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, et al.
Oncology Reports
|
February 11, 2017
First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report
Guillaume Meynard, Laura Mansi, Pierre Lebahar, et al.
World Journal of Gastrointestinal Oncology
|
March 25, 2020
FOLFOXIRI <i>vs</i> FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
Angélique Vienot, Hortense Chevalier, Clément Bolognini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 24, 2018
Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort
Claire Merveilleux du Vignaux, Eric Dansin, Laurent Mhanna, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Medical Oncology (Northwood, London, England)
|
July 13, 2016
Metronomic cyclophosphamide therapy in hormone-naive patients with non-metastatic biochemical recurrent prostate cancer: a phase II trial
Fabien Calcagno, Guillaume Mouillet, Olivier Adotevi, et al.
Frontiers in Oncology
|
March 28, 2022
Interest of the Addition of Taxanes to Standard Treatment in First-Line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients
Emeline Orillard, Julie Henriques, Dewi Vernerey, et al.
Journal of Adolescent and Young Adult Oncology
|
February 27, 2026
Impact of Social Media on Adolescents and Young Adults with Solid Tumors or Hematological Malignancies: A Multicenter Study
Sophie Martin, Justine Gantzer, Natacha Entz-Werle, et al.
Bulletin Du Cancer
|
July 5, 2020
[Systemic treatment of locally advanced or metastatic penile cancer]
Noémie Gassian, Alexandre Frontczak, Antoine El Kaddissi, et al.
Trials
|
April 14, 2018
Open-label, randomized multicentre phase II study to assess the efficacy and tolerability of sunitinib by dose administration regimen (dose modification or dose interruptions) in patients with advanced or metastatic renal cell carcinoma: study protocol of the SURF trial
Guillaume Mouillet, Marie-Justine Paillard, Tristan Maurina, et al.
Stem Cells (Dayton, Ohio)
|
May 10, 2008
Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney
Céline Mias, Elodie Trouche, Marie-Hélène Seguelas, et al.
Bulletin Du Cancer
|
October 1, 2021
[Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network]
Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, et al.
Oncology Reports
|
February 11, 2017
First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report
Guillaume Meynard, Laura Mansi, Pierre Lebahar, et al.
World Journal of Gastrointestinal Oncology
|
March 25, 2020
FOLFOXIRI <i>vs</i> FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
Angélique Vienot, Hortense Chevalier, Clément Bolognini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 24, 2018
Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort
Claire Merveilleux du Vignaux, Eric Dansin, Laurent Mhanna, et al.
Page
of 3